Literature DB >> 27025981

Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.

Saba Ghazvini1, Cavan Kalonia2, David B Volkin3, Prajnaparamita Dhar4.   

Abstract

Mechanical agitation of monoclonal antibody (mAb) solutions often leads to protein particle formation. In this study, various formulations of an immunoglobulin G (IgG) 1 mAb were subjected to different controlled interfacial stresses using a Langmuir trough, and protein particles formed at the interface and measured in bulk solution were characterized using atomic force microscopy and flow digital imaging. Results were compared to mAb solutions agitated in glass vials and unstressed controls. At lower pH, mAb solutions exhibited larger hysteresis in their surface pressure versus area isotherms and increased number of particles in bulk solution, when subjected to interfacial stresses. mAb samples subjected to 750-1000 interfacial compression-expansion cycles in 6 h contained high particle numbers in bulk solution, and displayed similar particulation trends when agitated in vials. At compression rates of 50 cycles in 6 h, however, particle levels in mAb solutions were comparable to unstressed controls, despite protein aggregates being present at the air-solution interface. These results suggest that while the air-solution interface serves as a nucleation site for initiating protein aggregation, the number of protein particles measured in bulk mAb solutions depends on the total number of compression cycles that proteins at the air-solution interface are subjected to within a fixed time.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IgG; aggregation; agitation; air-solution interface; controlled compression-expansion; formulation; interfacial; monoclonal antibody; protein; stability

Mesh:

Substances:

Year:  2016        PMID: 27025981     DOI: 10.1016/j.xphs.2016.02.027

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

2.  Protein Adsorption and Layer Formation at the Stainless Steel-Solution Interface Mediates Shear-Induced Particle Formation for an IgG1 Monoclonal Antibody.

Authors:  Cavan K Kalonia; Frank Heinrich; Joseph E Curtis; Sid Raman; Maria A Miller; Steven D Hudson
Journal:  Mol Pharm       Date:  2018-02-20       Impact factor: 4.939

Review 3.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 4.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

5.  Surfaces Affect Screening Reliability in Formulation Development of Biologics.

Authors:  Mitja Zidar; Gregor Posnjak; Igor Muševič; Miha Ravnik; Drago Kuzman
Journal:  Pharm Res       Date:  2020-01-06       Impact factor: 4.200

6.  Machine Learning Analysis Provides Insight into Mechanisms of Protein Particle Formation Inside Containers During Mechanical Agitation.

Authors:  Nidhi G Thite; Saba Ghazvini; Nicole Wallace; Naomi Feldman; Christopher P Calderon; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2022-07-11       Impact factor: 3.784

7.  Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.

Authors:  Neha N Pardeshi; Chen Zhou; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2018-03-27       Impact factor: 3.534

8.  A Mechanistic Understanding of Monoclonal Antibody Interfacial Protection by Hydrolytically Degraded Polysorbate 20 and 80 under IV Bag Conditions.

Authors:  Aadithya Kannan; Jamie Giddings; Shrenik Mehta; Tiffany Lin; Anthony Tomlinson; Kyle Ritchie; Ian Shieh; Miguel Saggu; Nidhi Doshi
Journal:  Pharm Res       Date:  2022-03-11       Impact factor: 4.200

Review 9.  Recent Advances in Studying Interfacial Adsorption of Bioengineered Monoclonal Antibodies.

Authors:  Peter Hollowell; Zongyi Li; Xuzhi Hu; Sean Ruane; Cavan Kalonia; Christopher F van der Walle; Jian R Lu
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

10.  Full-length G glycoprotein directly extracted from rabies virus with detergent and then stabilized by amphipols in liquid and freeze-dried forms.

Authors:  Didier Clénet; Léna Clavier; Benoît Strobbe; Christel Le Bon; Manuela Zoonens; Aure Saulnier
Journal:  Biotechnol Bioeng       Date:  2021-08-05       Impact factor: 4.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.